Empagliflozin Tablets 10 mg, 25 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 10 mg, 25 mg
Reference Brands: Jardiance(EU & US), Glyxet (India)
Category: Diabetes
Empagliflozin, an SGLT2 inhibitor, blocks glucose reabsorption in kidneys, promoting urinary glucose excretion. This lowers blood sugar in type 2 diabetes. Benefits include improved glycemic control, weight loss, blood pressure reduction, and cardiovascular risk reduction, with a low risk of hypoglycemia.
Product Description:
Empagliflozin is a selective SGLT2 inhibitor approved for managing type 2 diabetes mellitus, heart failure, and chronic kidney disease. In the USA, the FDA approved Jardiance (10 mg, 25 mg) in 2014. In the EU, it is authorized by the EMA under centralized procedure. It is often prescribed as monotherapy or in combination with metformin or insulin. Empagliflozin improves glycemic control and reduces cardiovascular risks. Regular renal monitoring is advised. Pharmatradz.com connects global buyers and suppliers with licensed manufacturers of Empagliflozin, ensuring regulatory-compliant sourcing for B2B needs in both regulated and semi-regulated markets.
Empagliflozin Tablets — third party manufacturing & bulk supply
Empagliflozin Tablets 10 mg, 25 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Empagliflozin Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Empagliflozin Tablets →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Empagliflozin is used to manage Type 2 diabetes mellitus. It helps lower blood sugar levels, reduce cardiovascular risk in patients with diabetes and heart disease, and support weight reduction.
Empagliflozin is a synthetic small-molecule drug and an SGLT2 (sodium-glucose co-transporter 2) inhibitor, which blocks glucose reabsorption in the kidneys, promoting its excretion through urine.
The main trade name is Jardiance.
Empagliflozin is manufactured by Boehringer Ingelheim in collaboration with Eli Lilly.
The generic name is Empagliflozin.
The brand name is Jardiance.
Empagliflozin is manufactured in Europe and the USA and distributed globally, including the USA, EU, India, and Japan.
Related Products
Pioglitazone Hydrochloride 150Mg Tablet
Strength:
15 mg, 30 mg, 45 mg
Form: Tablets
Reference Brands: Actos (USA)
View Details
Nateglinide
Strength:
60 mg, 120 mg, 180 mg
Form: Tablets
Reference Brands: Starlix (USA)
View Details
Miglitol
Strength:
25 mg, 50 mg, 100 mg
Form: Tablets
Reference Brands: Glyset (USA), Diastabol (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
